Member Info for MisterPositive

Jolly
Numbers are staggering. Even we take just 60% of the £1B.....we sitting on a potential 10 x Bagger at GDR.

I think we are very close to next RNS and they will come as back to back RNS magnifying the upside which is waiting to happen.

Stacked veins
15km strike length
High grades
Free carry
Royalties income
Investments in other highly attractive projects

Just far too much upside here from current MCap.

coiled spring...comes to mind.
Hmmm

correction *

$4.2 Billion Operating Profit (not revenue).

$2.05 Billion profit (from Life Sciences division)
$1.54 Billion profit (from Diagnostics division)

yuyus,
Appreciate that Sir. I know where you coming from. We all been there. Many of us have our share of losses.

Point i was trying to illustrate is Market is 'Forward Looking' and re-rates on future outlook. Beckman Coulter deal is huge as we all know and it changes the whole dynamics going forward. You only need your 'FIRST' major breakthrough deal and rest follow. We not even looked at other news that is due on multiple fronts.

Just listened to the CEO interview, and he said this deal is very material and Significant for GeneDrive. Beckman Coulter are keeping their numbers confidential. Obviously USA is Beckman home ground with big market share of US market.

Danaher Corp reported $4.2B revenue last year, $3B of which came from Life Sciences & Dignotics divisions.

Now with 'Accelerated testing' starting in USA, Genedrive is in an excellent and very lucrative place.

Good luck to ALL.

Yuyus.
Many of us were in those. So we know all about it

This is totally different industry /sector and GDR got a strong niche. Forecasts are estimates from the major deal struck with Beckman Coulter. Those figures could be revised higher. Folks here have just used low estimates for starters.

Market is forward looking. Right comparison should be with NCYT which hit peak of £900m Mcap last year.

GDR Mcap £62m ?
Re-rate here is inevitable.

Your chosen heading will obviously atract few derampers here.

GDR about to start firing on all cylinders.

Projected revenues here could be well over £300m which would be at the low end of estimates.

There is a huge re-rate underway without any doubt.

Yes BGH was bit of a drag but the buying pressure this week sucked all their shares like a Sponge. Otherwise we would have been over 125p min

They probably done here. TR1 gets reported late.

Nice buy.

They should well from this low price.

Will take 100p on GOOGLE.

Bid-Ask: 99 - 100

As long as I can see 100p somewhere, job done

Cannot wait for next week.

We were just warming up...

Not sold any. So hard to buy these....LoL

Still in Accumulating mode.

I can already see Zak Mir staying with GDR for the whole year with higher revisions regularly.

MCap here is way too low.

Chesser next door sitting at 3x ORR Mcap...nuts

This will correct itself in one giant swoop when IAMGOLD drilling results come through.

Poker chips
Nice one.

Yes US market alone is monumental.

We not even done rough figures for Europe.

Maybe over the weekend we can share passenger traffic, etc. That will just be for the airports.

Our revenues are going to Multiples of current Mcap ??? Should be other way round.

Re-rate here is simply inevitable.

Even £5 will look cheap.

Demand is going to be even stronger next week

This will now gain further coverage on the risers board.

Wolf is onboard already.

We all sitting in the same carriage. LOL

and the parent Danaher Corporation with around $170 Billion Mcap with huge market share in their field in USA.

Can you imagine, the massive revenues $$$ Genedrive will be getting from testing all over the US.

Some folks just don't realise where this share is headed in coming weeks starting Monday.

Terrier
12:51 post.....hilarious. LoL

Picked few more @ 99p

Going well over £1 next week.

Hold strong folks.

2021 should be a good one.